TFX Stock Overview
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 6/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for TFX from our risk checks.
Teleflex Incorporated Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$206.71 |
| 52 Week High | US$276.43 |
| 52 Week Low | US$177.63 |
| Beta | 1.12 |
| 1 Month Change | -8.60% |
| 3 Month Change | -16.32% |
| 1 Year Change | -24.15% |
| 3 Year Change | -51.07% |
| 5 Year Change | -31.18% |
| Change since IPO | 55,076.81% |
Recent News & Updates
What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?
Apr 21
Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes
Mar 06Recent updates
What Is Teleflex Incorporated's (NYSE:TFX) Share Price Doing?
Apr 21Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes
Mar 06Teleflex Incorporated (NYSE:TFX) Shares Could Be 32% Below Their Intrinsic Value Estimate
Feb 19Is Teleflex (NYSE:TFX) A Risky Investment?
Feb 02Getting In Cheap On Teleflex Incorporated (NYSE:TFX) Might Be Difficult
Jan 17Is Now An Opportune Moment To Examine Teleflex Incorporated (NYSE:TFX)?
Dec 31Returns On Capital At Teleflex (NYSE:TFX) Have Hit The Brakes
Nov 13We Think Teleflex (NYSE:TFX) Can Stay On Top Of Its Debt
Oct 29Teleflex Incorporated (NYSE:TFX) Shares Could Be 46% Below Their Intrinsic Value Estimate
Oct 13Teleflex Shares Hit Hard As Growth Concerns Stack Up
Oct 13Should You Investigate Teleflex Incorporated (NYSE:TFX) At US$200?
Sep 27Here's What To Make Of Teleflex's (NYSE:TFX) Decelerating Rates Of Return
Aug 07Teleflex: Flexing Its Muscles A Bit
Jul 27Is Teleflex (NYSE:TFX) A Risky Investment?
Jul 20Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 40% Above Its Share Price
Jul 05Teleflex: Now Investment Grade On 16% Projected Growth For Owner Earnings
Jun 22What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?
Jun 20Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger
May 05These 4 Measures Indicate That Teleflex (NYSE:TFX) Is Using Debt Reasonably Well
Apr 17Teleflex Incorporated's (NYSE:TFX) Intrinsic Value Is Potentially 37% Above Its Share Price
Mar 31At US$223, Is Teleflex Incorporated (NYSE:TFX) Worth Looking At Closely?
Mar 14Teleflex's 2 catheter devices get FDA clearance
Feb 22Teleflex (NYSE:TFX) Hasn't Managed To Accelerate Its Returns
Jan 27Teleflex (NYSE:TFX) Has A Pretty Healthy Balance Sheet
Jan 12Teleflex Already Getting A Pretty Good Benefit Of The Doubt
Jan 11An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 25% Undervalued
Dec 28What Does Teleflex Incorporated's (NYSE:TFX) Share Price Indicate?
Dec 12Teleflex recalls over 2.7M bacterial filters – FDA
Nov 01Teleflex: More Constructive Following Recent Weakness, Valuations Noteworthy
Oct 25Investors Met With Slowing Returns on Capital At Teleflex (NYSE:TFX)
Oct 17Is Teleflex (NYSE:TFX) Using Too Much Debt?
Oct 03Is Teleflex Incorporated (NYSE:TFX) Trading At A 44% Discount?
Sep 05Teleflex to acquire Standard Bariatrics for $170M
Aug 22Why Teleflex Incorporated (NYSE:TFX) Could Be Worth Watching
Aug 08Telefex: Valuations Are Stretched, Lack Of Risk Premia To Harvest
Jul 25Teleflex (NYSE:TFX) Has Some Way To Go To Become A Multi-Bagger
Jul 12Teleflex' Urolift System shows positive data in five studies to treat enlarged prostate
Jul 01Does Teleflex (NYSE:TFX) Have A Healthy Balance Sheet?
Jun 27Are Investors Undervaluing Teleflex Incorporated (NYSE:TFX) By 37%?
May 30Shareholder Returns
| TFX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0.07% | 2.1% | 2.9% |
| 1Y | -24.1% | -1.9% | 22.2% |
Return vs Industry: TFX underperformed the US Medical Equipment industry which returned -1.9% over the past year.
Return vs Market: TFX underperformed the US Market which returned 22.2% over the past year.
Price Volatility
| TFX volatility | |
|---|---|
| TFX Average Weekly Movement | 3.6% |
| Medical Equipment Industry Average Movement | 7.3% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.6% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: TFX has not had significant price volatility in the past 3 months.
Volatility Over Time: TFX's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1943 | 14,500 | Liam Kelly | www.teleflex.com |
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
Teleflex Incorporated Fundamentals Summary
| TFX fundamental statistics | |
|---|---|
| Market cap | US$9.74b |
| Earnings (TTM) | US$357.57m |
| Revenue (TTM) | US$2.97b |
27.2x
P/E Ratio3.3x
P/S RatioIs TFX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TFX income statement (TTM) | |
|---|---|
| Revenue | US$2.97b |
| Cost of Revenue | US$1.33b |
| Gross Profit | US$1.65b |
| Other Expenses | US$1.29b |
| Earnings | US$357.57m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 02, 2024
| Earnings per share (EPS) | 7.59 |
| Gross Margin | 55.37% |
| Net Profit Margin | 12.02% |
| Debt/Equity Ratio | 41.6% |
How did TFX perform over the long term?
See historical performance and comparison